Hence, this study compared the original PEPI to a modified p-PgR status alone and a modified PEPI including the PgR status (PEPI-P) as a prognostic factor for NAE in postmenopausal patients with ER-positive and HER2-negative breast cancer. This evidence concerns the gene PGR and breast carcinoma.